Medication Management for People with Dementia
Related Experiment Video
Updated: Mar 8, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Allison Lindauer1, Kathryn Sexson, Theresa A Harvath
1Allison Lindauer is an assistant professor at Oregon Health and Science University, Portland. Kathryn Sexson is a family NP at Denali Family Healthcare and an assistant professor in the School of Nursing, University of Alaska, Anchorage. Theresa A. Harvath is the associate dean for academics in the Betty Irene Moore School of Nursing, University of California, Davis, in Sacramento. The authors would like to acknowledge Susan C. Reinhard and Heather M. Young, leaders of the No Longer Home Alone video project, and the contributions of Carol Levine, who conducted focus groups with family caregivers regarding the challenges of medication management. Contact author: Allison Lindauer, lindauer@ohsu.edu. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
This article is the fourth in a series, Supporting Family Caregivers: No Longer Home Alone, published in collaboration with the AARP Public Policy Institute. Results of focus groups conducted as part of the AARP Public Policy Institute's No Longer Home Alone video project supported evidence that family caregivers aren't being given the information they need to manage the complex care regimens of their family members. This series of articles and accompanying videos aims to help nurses provide caregivers with the tools they need to manage their family member's medications. Each article explains the principles nurses should consider and reinforce with caregivers and is accompanied by a video for the caregiver to watch. The fourth video can be accessed at http://links.lww.com/AJN/A78.
Related Concept Videos
Drug Dosing: Geriatric Patients
Drug Therapy
Antianxiety Medications
Alzheimer's Disease: Treatment
Dementia
The progression of dementia is generally gradual....
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Pharmacodynamics in Geriatric Patients: Effects of Age

